HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bonne Bell recalls cosmetics bags

This article was originally published in The Rose Sheet

Executive Summary

The U.S. Consumer Product Safety Commission announces voluntary recall of Bonne Bell children's cosmetics accessory bags due to lead exposure risk, commission says Aug. 29. Metal clasps on bag's handle contain excessive amounts of lead and could pose risk of adverse health effects to children who play with the item, the commission says. Company notes that there have been no reports of injuries related to the bag and that cosmetics included in the bags are safe and not included in the recall. Bags from Smackers Sweet Treats, Sparkle & Shine and Glam It Up collections, as well as Bonnebell Natural Neutrals, Pretty Pinks, Fresh Pinks and Glamorous Neutrals collections, are affected, for a total of about 945,000 units. Consumers are advised to take bag away from children and contact Bonne Bell for a replacement bag. "The Bonne Bell Company solemnly regrets any inconvenience and apologizes for any concern caused by this product recall. The Company hopes that its consumers will continue to enjoy Smackers and Bonnie Bell products with confidence," firm says in statement to "The Rose Sheet.

You may also be interested in...

Corindus Envisions Network Of CorPath Robots For Remote Neurovascular And Coronary Interventions

The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.

MTI Top 100: Leading Medtechs See Steady Organic Growth In A Market On The Cusp Of Change

The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings. 

Hikma And Civica Ship Eight Essential Injectables

Hikma and Civica Rx have announced the launch of a first wave of eight essential injectable medicines, including heparin, as part of a deal struck between the two firms earlier this year.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts